Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 Amino Piperidine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel water-based resolution method for S-3-aminopiperidine. High purity 99.5% yield 72%. Cost-effective pharmaceutical intermediate supply chain solution.
Novel Ru-catalyzed asymmetric hydrogenation route for Niraparib intermediate. High yield, scalable process for pharmaceutical supply chains.
Patent CN103113290A details a cost-effective Pd/C catalyzed route for 3-methylaminopiperidine, offering significant supply chain advantages for fluoroquinolone producers.
Patent CN103554082B details a safer scalable route for 3-(4-amino-1-isoindolone-2-yl) piperidine-2,6-diketone manufacturing reducing toxic waste and operational hazards significantly.
Advanced synthesis of 3-aminopiperidine-2,6-dione hydrochloride via L-glutamic acid cyclization. Offers superior purity, reduced toxicity, and cost-effective scaling for pharmaceutical supply chains.
Advanced preparation method for (R)-1-Boc-3-aminopiperidine via chiral resolution. Safe, scalable process for DPP-IV inhibitor intermediates with reduced costs.
Novel catalytic hydrogenation route for Lenalidomide. High purity, reduced solvent use, scalable manufacturing for API intermediates.
Novel copper-catalyzed radical coupling method for chiral 3-aminopiperidine. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN109134351B details a novel synthesis of S-3-(4-aminophenyl)piperidine with >99% ee, offering cost-effective scalability for PARP inhibitor manufacturing.
Patent CN104837817B introduces a safer water-based synthesis route for 3-amino-piperidine intermediates enabling cost reduction and reliable supply for pharmaceutical manufacturing.